104 results
Page 3 of 6
8-K
EX-99.2
e3ul2flc6wp2 7s4vws
23 Jun 20
Millendo Therapeutics Provides Corporate and Pipeline Update
8:36am
8-K
EX-99.1
7bcgr63 d00v
6 Apr 20
Cost Associated with Exit or Disposal Activities
7:16am
8-K
EX-99.1
k88 ox8vl
10 Feb 20
Millendo Therapeutics Appoints Christophe Arbet-Engels, MD, PhD, as Chief Medical Officer
8:42am
8-K
EX-99.1
24rp1 kbzh0881
19 Dec 19
Geoff Nichol Appointed to Millendo Therapeutics Board of Directors
8:31am
8-K
EX-99.1
sczk0ckzfv2yxx1ubk9
5 Dec 19
Millendo Therapeutics Announces Proposed Public Offering of Common Stock
4:08pm
8-K
EX-99.2
9gp8s me75a
5 Dec 19
Millendo Therapeutics Announces Proposed Public Offering of Common Stock
4:08pm
8-K
EX-10.1
pttapwwc
17 Apr 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
pfxz kvurtw
29 Mar 19
Millendo Reports Full Year 2018 Operating and Financial Results
7:20am
8-K
EX-10.2
2yahws 510
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
EX-10.3
4yljutkac7brzvbeuw3s
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
7t9d0h9 ep69ylo
6 Dec 18
Entry into a Material Definitive Agreement
6:18am